Working… Menu

Effectiveness of Astym Treatment For de Quervain's Tenosynovitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02442622
Recruitment Status : Recruiting
First Posted : May 13, 2015
Last Update Posted : May 10, 2019
Information provided by (Responsible Party):
NYU Langone Health

Brief Summary:
To determine if the addition of Astym treatment to traditional therapy produces a more positive outcome then traditional therapy alone for the treatment of de Quervain's tenosynvitis. Two groups will be examined with one group receiving traditional therapy and the other group receiving traditional therapy in addition to Astym treatment protocol.

Condition or disease Intervention/treatment Phase
de Quervain's Disease Other: Occupational therapy Device: Occupational therapy with ASTYM Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 32 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effectiveness of Astym Treatment For de Quervain's Tenosynovitis
Actual Study Start Date : January 2015
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2019

Arm Intervention/treatment
Active Comparator: Occupational therapy
Traditional therapy for de Quervain's Tenosynovitis
Other: Occupational therapy
Occupational therapy for de Quervain's Tenosynovitis

Experimental: Occupational therapy with ASTYM
Traditional therapy for de Quervain's Tenosynovitis plus ASTYM
Device: Occupational therapy with ASTYM
Occupational therapy for de Quervain's Tenosynovitis plus ASTYM

Primary Outcome Measures :
  1. Numeric Rating Scale for Pain [ Time Frame: 4.5 months ]
    This scale is a single point scale from 0-10. The participant picks one number to represent their pain, where 0 represents no pain and 10 represents worst pain imaginable.

Secondary Outcome Measures :
  1. Sequential Occupational Dexterity Assessment [ Time Frame: 1.5 months ]
  2. Quick Dash [ Time Frame: 4.5 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

i. Positive Finkelstein's test: The client will report pain over the first compartment of the extensor retinaculum when the thumb is tucked in the hand and deviated ulnarly.

ii. Persistent symptoms for >3 wks which have not resolved after an additional 3 weeks of splinting

iii. A diagnosis by a physician of "de Quervain's", "fist compartment tenosynovitis", or "radial styloid tenosynovitis"

iv. Patients must agree and comply to a predetermined splinting regimen

Exclusion Criteria:

i. History of cortical steroid injection to affected wrist and/or thumb

ii. History of previous wrist trauma to affected limb

iii. Comorbidity such as carpal tunnel syndrome (CTS), radial tunnel syndrome, osteoarthritis, rheumatoid arthritis, auto-immune disease or inflammatory conditions, lateral epicondylitis or tendinopathies

iv. Clotting deficits

v. Positive Cozen's sign which would indicate intersection syndrome

vi. Post-partum mothers <6 months and pregnant women

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02442622

Layout table for location contacts
Contact: April O'Connell, OTR/L, CHT (646) 501-7077

Layout table for location information
United States, New York
NYU Langone Medical Center, Center for Musculoskeletal Care Recruiting
New York, New York, United States, 10016
Contact: April O'Connell, OTR/L,CHT    646-501-7707   
Contact: Daniel Geller, MS,MPH,OTR/L    646-501-7753   
Sponsors and Collaborators
NYU Langone Health
Layout table for investigator information
Principal Investigator: Stephen VanLew, MS, OTR/L NYU Langone Medical Center

Layout table for additonal information
Responsible Party: NYU Langone Health Identifier: NCT02442622     History of Changes
Other Study ID Numbers: 14-01059
First Posted: May 13, 2015    Key Record Dates
Last Update Posted: May 10, 2019
Last Verified: May 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Device Product Not Approved or Cleared by U.S. FDA: No
Pediatric Postmarket Surveillance of a Device Product: No
Keywords provided by NYU Langone Health:
de Quervain's disease
de Quervain's tenosynovitis.
de Quervain's treatment
Additional relevant MeSH terms:
Layout table for MeSH terms
De Quervain Disease
Muscular Diseases
Musculoskeletal Diseases
Tendon Entrapment